In another study, it was also confirmed that FGL2 activates this pathway and the NLRP3 inflammasome aggravated nonalcoholic steatohepatitis (NASH) and promoted lipid metabolism disorders 69. The gene discussed is NLRP3; the disease is metabolic dysfunction-associated steatohepatitis.